ストックスクリーナーアプリを入手
0.92
3.36%
0.0299
アフターアワーズ：
.90
-0.02
-2.17%
前日終値:
$0.8901
開ける：
$0.89
24時間の取引高:
73,470
Relative Volume:
1.21
時価総額：
$5.40M
収益：
-
当期純損益:
$-24.47M
株価収益率:
-0.9388
EPS:
-0.98
ネットキャッシュフロー:
$-24.56M
1週間 パフォーマンス:
-19.30%
1か月 パフォーマンス:
-34.29%
6か月 パフォーマンス:
-66.05%
1年 パフォーマンス:
-86.17%
1日の値動き範囲:
$0.8836
$0.96
1週間の範囲:
$0.8467
$1.20
52週間の値動き範囲:
$0.8467
$13.61
Evaxion Biotech A S Adr Stock (EVAX) Company Profile
EVAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion Biotech A S Adr
|
0.92 | 5.40M | 0 | -24.47M | -24.56M | -9.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Evaxion Biotech A S Adr Stock (EVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-02 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | 開始されました | H.C. Wainwright | Buy |
Evaxion Biotech A S Adr (EVAX) 最新ニュース
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Fall in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.92 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week - MSN
European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN
Evaxion achieves preclinical success with AI cancer vaccine - Investing.com
Evaxion Biotech stock hits 52-week low at $1.19 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $1.31 By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $1.31 - Investing.com
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
Evaxion appeals Nasdaq delisting determination - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week - MSN
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - MSN
Evaxion Biotech Reports Q3 Progress and Financials - TipRanks
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Friday - MSN
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN
Evaxion reports improved AI vaccine target predictions - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle
EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Evaxion Biotech inks vaccine licensing deal with MSD - Investing.com
Evaxion stock jumps on expanded vaccine development pact with MSD - MSN
Evaxion stock jumps on expanded vaccine development pact with MSD (NASDAQ:EVAX) - Seeking Alpha
H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com
Evaxion Biotech enhances AI vaccine discovery platform - Investing.com
Evaxion Biotech A S Adr (EVAX) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):